Attached files

file filename
EX-99.1 - Infusion Brands International, Inc.v207944_ex99-1.htm
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  January 11, 2010
 
Infusion Brands International, Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
000-51599
54-2153837
(State or Other Jurisdiction
(Commission File
(I.R.S. Employer
of Incorporation)
Number)
Identification Number)
 
14375 Myerlake Circle
Clearwater, FL 33760 
 (Address of principal executive offices) (zip code)

 (727) 230-1031
(Registrant's telephone number, including area code)

OmniReliant Holdings, Inc.
(Former name or former address, if changed since last report)

Copies to:
Darrin M. Ocasio, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Floor
New York, New York 10006
Phone: (212) 930-9700
Fax: (212) 930-9725

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 

On January 11, 2011, Infusion Brands International, Inc. (the “Company”) issued a press release announcing a change in its ticker symbol to “INBI”, effective January 7, 2011.  The press release is attached hereto as Exhibit 99.1.
 
Item 9.01. Financial Statements and Exhibits
 
(c) Exhibits.
 
      99.1    
Press Release dated January 11, 2011


 
 

 

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Infusion Brands International, Inc.
   
Dated: January 12, 2011
By:  /s/ Robert DeCecco
 
Name:  Robert DeCecco
 
Title:   Chief Executive Officer